Subscribe
John Squires, who delivered his first public remarks in Washington, DC after becoming USPTO president
EPNAC.com
1 November 2025NewsAmericasSarah Speight

Squires: ‘Inherited patent backlog was an absolute dumpster fire’

In his first public remarks since becoming the USPTO director, a bombastic John Squires promises an agency “in overdrive” that's doubling down on AI, reports Sarah Speight.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
End of the ‘Death Squad’? Squires puts PTAB on trial
22 October 2025   Just weeks into his tenure, USPTO director John Squires is blitzing US patent policy by taking control of how and when patent challenges can be brought, with proposed rules that could sharply limit repeat and parallel filings. Sarah Speight gauges reaction.
Americas
‘All it takes is a post on Truth Social’: Is this patent reform's moment?
17 October 2025   A US Senate subcommittee hearing on patent eligibility reform has David Kappos, former USPTO director, believing that “there’s a better chance than ever” of a pending bill becoming law, finds Sarah Speight.
Americas
All eyes on Squires: What IP experts want from the new USPTO director
23 September 2025   As John Squires is confirmed as the US Patent and Trademark Office's new director, Sarah Speight gathers reaction, and asks: what would you ask the US’ chief IP executive?


Editor's picks

Why AI is changing the patent rules faster than anyone can keep up
Americas
Why AI is changing the patent rules faster than anyone can keep up
24 October 2025

Editor's picks

Americas
Why AI is changing the patent rules faster than anyone can keep up
24 October 2025
Americas
LSPN panel unpacks critical IP risks in deal-making
23 October 2025
Americas
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
23 October 2025
Americas
Data and delivery: Inside AI's inventorship dilemma
21 October 2025
Americas
Top pharma, biotech, and medtech experts gather at LSPN Fall
21 October 2025
Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
16 October 2025

More features

Novartis counsel warns: ‘Don’t let AI develop without our input’
Delegates descend upon Washington, DC for AIPLA Annual Meeting
Novo Nordisk counters rival with $9bn bid for obesity drug developer
‘We're being attacked from all sides’: Thermo Fisher Scientific counsel
China trademarks rankings reveal new entries, hidden gems and big brands
Edwards defends key heart valve product from infringement threat
Is AI emerging as the ‘fourth party’ solving billion-dollar disputes?
The hidden code in life sciences deals